Notable Biotech Analyst Jason Napodano Comments On Valeant, Horizon, And Specialty Pharmacies
October 22, 2015 at 13:38 PM EDT
In A Benzinga exclusive interview, Jason Napodano highlighted these key thoughts: Aggressive biotech companies that don't do R&D are ...